NCT04197622View on ClinicalTrials.gov

Generation of Biological Samples Positive to Hydrochlorothiazide for Anti-doping Control

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

March 21, 2019

Study Completion Date

March 21, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Hydrochlorothiazide

12,5 mg of hydrochlorothiazide (1/2 tablet of 25 mg) administered orally in a single dose.

Trial Locations (1)

08003

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT04197622 - Generation of Biological Samples Positive to Hydrochlorothiazide for Anti-doping Control | Biotech Hunter | Biotech Hunter